Acquisition by Allen Jim L. of 50000 shares of Biocardia at 3.0 subject to Rule 16b-3

BCDA Stock  USD 2.13  0.11  4.91%   
About 62% of Biocardia's investor base is looking to short. The analysis of the overall investor sentiment regarding Biocardia suggests that many traders are alarmed. The current market sentiment, together with Biocardia's historical and current headlines, can help investors time the market. In addition, many technical investors use Biocardia stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Biocardia Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at macroaxis.com
Acquisition of 50000 common stock at 3.0 of Biocardia by Allen Jim L. on 3rd of September 2024. This event was filed by Biocardia with SEC on 2024-09-03. Statement of changes in beneficial ownership - SEC Form 4

Biocardia Fundamental Analysis

We analyze Biocardia's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biocardia using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biocardia based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Total Asset

Total Asset Comparative Analysis

Biocardia is currently under evaluation in total asset category among its peers. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.

Biocardia Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biocardia stock to make a market-neutral strategy. Peer analysis of Biocardia could also be used in its relative valuation, which is a method of valuing Biocardia by comparing valuation metrics with similar companies.

Peers

Biocardia Related Equities

ABVCABVC Biopharma   3.77   
0%
27.0%
NGENFNervGen Pharma   0.95   
0%
6.0%
ADAGAdagene   0.51   
3.0%
0%
INDPIndaptus Therapeutics   2.06   
14.0%
0%
AVTEAerovate Therapeutics   3.41   
24.0%
0%
ANTXAN2 Therapeutics   3.85   
27.0%
0%
RZLTRezolute   5.95   
43.0%
0%
FBRXForte Biosciences   8.54   
61.0%
0%
KTTAPasithea Therapeutics   8.57   
62.0%
0%
ACRVAcrivon Therapeutics,   10.33   
74.0%
0%
ANEBAnebulo Pharmaceuticals   10.43   
75.0%
0%
MLYSMineralys Therapeutics,   11.87   
85.0%
0%
PTIXProtagenic Therapeutics   12.73   
92.0%
0%
ERASErasca   13.82   
100.0%
0%

Complementary Tools for Biocardia Stock analysis

When running Biocardia's price analysis, check to measure Biocardia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biocardia is operating at the current time. Most of Biocardia's value examination focuses on studying past and present price action to predict the probability of Biocardia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biocardia's price. Additionally, you may evaluate how the addition of Biocardia to your portfolios can decrease your overall portfolio volatility.
Money Managers
Screen money managers from public funds and ETFs managed around the world
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Transaction History
View history of all your transactions and understand their impact on performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges